Cargando…

Pre-clinical and Clinical Safety Studies of CMX-2043: A Cytoprotective Lipoic Acid Analogue for Ischaemia–Reperfusion Injury

CMX-2043 is an α-lipoic acid analogue targeted to reduction of cellular injury and organ damage due to ischaemia–reperfusion injury (IRI). It has been shown to be effective in a rat model of cardiac IRI. The studies here reported evaluate its safety and pharmacokinetic profile in preparation for hum...

Descripción completa

Detalles Bibliográficos
Autores principales: Kates, Steven A, Lader, Alan S, Casale, Ralph, Beeuwkes, Reinier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270215/
https://www.ncbi.nlm.nih.gov/pubmed/24751172
http://dx.doi.org/10.1111/bcpt.12254

Ejemplares similares